<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37509182</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Yeast Models of Amyotrophic Lateral Sclerosis Type 8 Mimic Phenotypes Seen in Mammalian Cells Expressing Mutant VAPB<sup>P56S</sup>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1147</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom13071147</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease that results in the loss of motor neurons and can occur sporadically or due to genetic mutations. Among the 30 genes linked to familial ALS, a P56S mutation in <i>VAPB</i>, an ER-resident protein that functions at membrane contact sites, causes ALS type 8. Mammalian cells expressing VAPB<sup>P56S</sup> have distinctive phenotypes, including ER collapse, protein and/or membrane-containing inclusions, and sensitivity to ER stress. <i>VAPB</i> is conserved through evolution and has two homologs in budding yeast, <i>SCS2</i> and <i>SCS22</i>. Previously, a humanized version of <i>SCS2</i> bearing disease-linked mutations was described, and it caused Scs2-containing inclusions when overexpressed in yeast. Here, we describe a yeast model for ALS8 in which the two <i>SCS</i> genes are deleted and replaced with a single chromosomal copy of either wild-type or mutant yeast <i>SCS2</i> or human <i>VAPB</i> expressed from the <i>SCS2</i> promoter. These cells display ER collapse, the formation of inclusion-like structures, and sensitivity to tunicamycin, an ER stress-inducing drug. Based on the phenotypic similarity to mammalian cells expressing VAPB<sup>P56S</sup>, we propose that these models can be used to study the molecular basis of cell death or dysfunction in ALS8. Moreover, other conserved ALS-linked genes may create opportunities for the generation of yeast models of disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stump</LastName><ForeName>AnnaMari L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Biology, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VCU Life Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rioux</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Biology, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VCU Life Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albright</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biology, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melki</LastName><ForeName>Guiliano L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Biology, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prosser</LastName><ForeName>Derek C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0002-6738-2758</Identifier><AffiliationInfo><Affiliation>Department of Biology, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496748">VAPB protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C563895">Amyotrophic Lateral Sclerosis 8</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ALS8</Keyword><Keyword MajorTopicYN="N">Saccharomyces cerevisiae</Keyword><Keyword MajorTopicYN="N">VAPB</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">endoplasmic reticulum</Keyword><Keyword MajorTopicYN="N">membrane contact site</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">yeast</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37509182</ArticleId><ArticleId IdType="pmc">PMC10377116</ArticleId><ArticleId IdType="doi">10.3390/biom13071147</ArticleId><ArticleId IdType="pii">biom13071147</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the Mechanisms Involved in Motor Neuron Degeneration in ALS. Annu. Rev. Neurosci. 2004;27:723&#x2013;749. doi: 10.1146/annurev.neuro.27.070203.144244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Malik Z., Singh M., Rachana R., Mani S., Ponnusamy K., Haider S. Amyotrophic Lateral Sclerosis Risk Genes and Suppressor. Curr. Gene Ther. 2023;23:148&#x2013;162. doi: 10.2174/1566523223666221108113330.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566523223666221108113330</ArticleId><ArticleId IdType="pubmed">36366843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirola L., Mukherjee A., Mutsuddi M. Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Mol. Neurobiol. 2022;59:5673&#x2013;5694. doi: 10.1007/s12035-022-02934-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02934-z</ArticleId><ArticleId IdType="pubmed">35768750</ArticleId></ArticleIdList></Reference><Reference><Citation>Deerlin V.M.V., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP Mutations in Amyotrophic Lateral Sclerosis with TDP-43 Neuropathology: A Genetic and Histopathological Analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., Vos K.J.D., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller A., Bauer C.S., Cohen R.N., Webster C.P., Vos K.J.D. Amyotrophic Lateral Sclerosis-Associated Mutant SOD1 Inhibits Anterograde Axonal Transport of Mitochondria by Reducing Miro1 Levels. Hum. Mol. Genet. 2017;26:4668&#x2013;4679. doi: 10.1093/hmg/ddx348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx348</ArticleId><ArticleId IdType="pmc">PMC5886184</ArticleId><ArticleId IdType="pubmed">28973175</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., Jin S., Mancias P., Kiyama H., Yamanaka K. Mitochondria-Associated Membrane Collapse Is a Common Pathomechanism in SIGMAR1- and SOD1-Linked ALS. EMBO Mol. Med. 2016;8:1421&#x2013;1437. doi: 10.15252/emmm.201606403.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.-B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in IPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D., Chalhoub A., Schooley A., Zhang W., Ngsee J.K. A Mutation in VAPB That Causes Amyotrophic Lateral Sclerosis Also Causes a Nuclear Envelope Defect. J. Cell Sci. 2012;125:2831&#x2013;2836. doi: 10.1242/jcs.102111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.102111</ArticleId><ArticleId IdType="pubmed">22454507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y., Wang J., Henderson M.J., Yang P., Hagen B.M., Siddique T., Vogel B.E., Deng H.-X., Fang S. Nuclear Export of Misfolded SOD1 Mediated by a Normally Buried NES-like Sequence Reduces Proteotoxicity in the Nucleus. eLife. 2017;6:e23759. doi: 10.7554/eLife.23759.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.23759</ArticleId><ArticleId IdType="pmc">PMC5449186</ArticleId><ArticleId IdType="pubmed">28463106</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkas C., Middleton S., Kremer A.M., Wardrope C., Hannah M., Gillingwater T.H., Skehel P. VAPB Interacts with and Modulates the Activity of ATF6. Hum. Mol. Genet. 2008;17:1517&#x2013;1526. doi: 10.1093/hmg/ddn040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn040</ArticleId><ArticleId IdType="pubmed">18263603</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Kanekura K., Levine T.P., Kohno K., Olkkonen V.M., Aiso S., Matsuoka M. ALS-Linked P56S-VAPB, an Aggregated Loss-of-Function Mutant of VAPB, Predisposes Motor Neurons to ER Stress-Related Death by Inducing Aggregation of Co-Expressed Wild-Type VAPB. J. Neurochem. 2009;108:973&#x2013;985. doi: 10.1111/j.1471-4159.2008.05857.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05857.x</ArticleId><ArticleId IdType="pubmed">19183264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Suzuki H., Aiso S., Matsuoka M. ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2009;39:81&#x2013;89. doi: 10.1007/s12035-009-8054-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-009-8054-3</ArticleId><ArticleId IdType="pubmed">19184563</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagishi S., Koyama Y., Katayama T., Taniguchi M., Hitomi J., Kato M., Aoki M., Itoyama Y., Kato S., Tohyama M. An in Vitro Model for Lewy Body-like Hyaline Inclusion/Astrocytic Hyaline Inclusion: Induction by ER Stress with an ALS-Linked SOD1 Mutation. PLoS ONE. 2007;2:e1030. doi: 10.1371/journal.pone.0001030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001030</ArticleId><ArticleId IdType="pmc">PMC2000355</ArticleId><ArticleId IdType="pubmed">17925878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A., Vollrath J.T., Sechi A., Johann S., Roos A., Yamoah A., Katona I., Bohlega S., Wiemuth D., Tian Y., et al. The ALS-Linked E102Q Mutation in Sigma Receptor-1 Leads to ER Stress-Mediated Defects in Protein Homeostasis and Dysregulation of RNA-Binding Proteins. Cell Death Differ. 2017;24:1655&#x2013;1671. doi: 10.1038/cdd.2017.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.88</ArticleId><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva E.V., Ayala V., Jov&#xe9; M., Dalf&#xf3; E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., Portero-Ot&#xed;n M. Oxidative and Endoplasmic Reticulum Stress Interplay in Sporadic Amyotrophic Lateral Sclerosis. Brain. 2007;130:3111&#x2013;3123. doi: 10.1093/brain/awm190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm190</ArticleId><ArticleId IdType="pubmed">17716997</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosser D.C., Tran D., Gougeon P.Y., Verly C., Ngsee J.K. FFAT Rescues VAPA-Mediated Inhibition of ER-to-Golgi Transport and VAPB-Mediated ER Aggregation. J. Cell Sci. 2008;121:3052&#x2013;3061. doi: 10.1242/jcs.028696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.028696</ArticleId><ArticleId IdType="pmc">PMC3038994</ArticleId><ArticleId IdType="pubmed">18713837</ArticleId></ArticleIdList></Reference><Reference><Citation>Skehel P.A., Martin K.C., Kandel E.R., Bartsch D. A VAMP-Binding Protein from Aplysia Required for Neurotransmitter Release. Science. 1995;269:1580&#x2013;1583. doi: 10.1126/science.7667638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7667638</ArticleId><ArticleId IdType="pubmed">7667638</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Hayashi M., Inada H., Tanaka T. Molecular Cloning and Characterization of Mammalian Homologues of Vesicle-Associated Membrane Protein-Associated (VAMP-Associated) Proteins. Biochem. Biophys. Res. Commun. 1999;254:21&#x2013;26. doi: 10.1006/bbrc.1998.9876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1998.9876</ArticleId><ArticleId IdType="pubmed">9920726</ArticleId></ArticleIdList></Reference><Reference><Citation>Raychaudhuri S., Im Y.J., Hurley J.H., Prinz W.A. Nonvesicular Sterol Movement from Plasma Membrane to ER Requires Oxysterol-Binding Protein&#x2013;Related Proteins and Phosphoinositides. J. Cell Biol. 2006;173:107&#x2013;119. doi: 10.1083/jcb.200510084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200510084</ArticleId><ArticleId IdType="pmc">PMC2063795</ArticleId><ArticleId IdType="pubmed">16585271</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewen C.J.R., Levine T.P. A Highly Conserved Binding Site in Vesicle-Associated Membrane Protein-Associated Protein (VAP) for the FFAT Motif of Lipid-Binding Proteins. J. Biol. Chem. 2005;280:14097&#x2013;14104. doi: 10.1074/jbc.M500147200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500147200</ArticleId><ArticleId IdType="pubmed">15668246</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry R.J., Ridgway N.D. Oxysterol-Binding Protein and Vesicle-Associated Membrane Protein-Associated Protein are Required for Sterol-Dependent Activation of the Ceramide Transport Protein. Mol. Biol. Cell. 2006;17:2604&#x2013;2616. doi: 10.1091/mbc.e06-01-0060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e06-01-0060</ArticleId><ArticleId IdType="pmc">PMC1474796</ArticleId><ArticleId IdType="pubmed">16571669</ArticleId></ArticleIdList></Reference><Reference><Citation>Manford A.G., Stefan C.J., Yuan H.L., MacGurn J.A., Emr S.D. ER-to-Plasma Membrane Tethering Proteins Regulate Cell Signaling and ER Morphology. Dev. Cell. 2012;23:1129&#x2013;1140. doi: 10.1016/j.devcel.2012.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2012.11.004</ArticleId><ArticleId IdType="pubmed">23237950</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewen C.J.R., Young B.P., Tavassoli S., Levine T.P. Inheritance of Cortical ER in Yeast Is Required for Normal Septin Organization. J. Cell Biol. 2007;179:467&#x2013;483. doi: 10.1083/jcb.200708205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200708205</ArticleId><ArticleId IdType="pmc">PMC2064793</ArticleId><ArticleId IdType="pubmed">17984322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha N., Kuijl C., van der Kant R., Janssen L., Houben D., Janssen H., Zwart W., Neefjes J. Cholesterol Sensor ORP1L Contacts the ER Protein VAP to Control Rab7&#x2013;RILP&#x2013;P150Glued and Late Endosome Positioning. J. Cell Biol. 2009;185:1209&#x2013;1225. doi: 10.1083/jcb.200811005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200811005</ArticleId><ArticleId IdType="pmc">PMC2712958</ArticleId><ArticleId IdType="pubmed">19564404</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy S.E., Levine T.P. VAP, a Versatile Access Point for the Endoplasmic Reticulum: Review and Analysis of FFAT-like Motifs in the VAPome. Biochim. Biophys. Acta. 2016;1861:952&#x2013;961. doi: 10.1016/j.bbalip.2016.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2016.02.009</ArticleId><ArticleId IdType="pubmed">26898182</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C.A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R.M., Gillingwater T., Webb J., et al. A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitne-Neto M., Ramos C.R.R., Pimenta D.C., Luz J.S., Nishimura A.L., Gonzales F.A., Oliveira C.C., Zatz M. A Mutation in Human VAP-B-MSP Domain, Present in ALS Patients, Affects the Interaction with Other Cellular Proteins. Protein Expr. Purif. 2007;55:139&#x2013;146. doi: 10.1016/j.pep.2007.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2007.04.007</ArticleId><ArticleId IdType="pubmed">17540579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser S.E., Brickner J.H., Reilein A.R., Fenn T.D., Walter P., Brunger A.T. Structural Basis of FFAT Motif-Mediated ER Targeting. Structure. 2005;13:1035&#x2013;1045. doi: 10.1016/j.str.2005.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2005.04.010</ArticleId><ArticleId IdType="pubmed">16004875</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuling E., Ahmed S., Haasdijk E., Demmers J., Steinmetz M.O., Akhmanova A., Jaarsma D., Hoogenraad C.C. Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates. J. Neurosci. 2007;27:9801&#x2013;9815. doi: 10.1523/JNEUROSCI.2661-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2661-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672975</ArticleId><ArticleId IdType="pubmed">17804640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnaparkhi A., Lawless G.M., Schweizer F.E., Golshani P., Jackson G.R. A Drosophila Model of ALS: Human ALS-Associated Mutation in VAP33A Suggests a Dominant Negative Mechanism. PLoS ONE. 2008;3:e2334. doi: 10.1371/journal.pone.0002334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002334</ArticleId><ArticleId IdType="pmc">PMC2390852</ArticleId><ArticleId IdType="pubmed">18523548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda H., Han S.M., Yang Y., Tong C., Lin Y.Q., Mohan K., Haueter C., Zoghbi A., Harati Y., Kwan J., et al. The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors. Cell. 2008;133:963&#x2013;977. doi: 10.1016/j.cell.2008.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.04.039</ArticleId><ArticleId IdType="pmc">PMC2494862</ArticleId><ArticleId IdType="pubmed">18555774</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer J.W., Diehl J.A. PERK Mediates Cell-Cycle Exit during the Mammalian Unfolded Protein Response. Proc. Natl. Acad. Sci. USA. 2000;97:12625&#x2013;12630. doi: 10.1073/pnas.220247197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220247197</ArticleId><ArticleId IdType="pmc">PMC18814</ArticleId><ArticleId IdType="pubmed">11035797</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., Ron D. Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells. Mol. Cell. 2000;6:1099&#x2013;1108. doi: 10.1016/S1097-2765(00)00108-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)00108-8</ArticleId><ArticleId IdType="pubmed">11106749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H., Matsui T., Yamamoto A., Okada T., Mori K. XBP1 MRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor. Cell. 2001;107:881&#x2013;891. doi: 10.1016/S0092-8674(01)00611-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00611-0</ArticleId><ArticleId IdType="pubmed">11779464</ArticleId></ArticleIdList></Reference><Reference><Citation>Haze K., Yoshida H., Yanagi H., Yura T., Mori K. Mammalian Transcription Factor ATF6 Is Synthesized as a Transmembrane Protein and Activated by Proteolysis in Response to Endoplasmic Reticulum Stress. Mol. Biol. Cell. 1999;10:3787&#x2013;3799. doi: 10.1091/mbc.10.11.3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.10.11.3787</ArticleId><ArticleId IdType="pmc">PMC25679</ArticleId><ArticleId IdType="pubmed">10564271</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamichi S., Yamanaka K., Suzuki M., Watanabe T., Kagiwada S. Human VAPA and the Yeast VAP Scs2p with an Altered Proline Distribution Can Phenocopy Amyotrophic Lateral Sclerosis-Associated VAPB(P56S) Biochem. Biophys. Res. Commun. 2011;404:605&#x2013;609. doi: 10.1016/j.bbrc.2010.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.12.011</ArticleId><ArticleId IdType="pubmed">21144830</ArticleId></ArticleIdList></Reference><Reference><Citation>Longtine M.S., Mckenzie A., III, Demarini D.J., Shah N.G., Wach A., Brachat A., Philippsen P., Pringle J.R. Additional Modules for Versatile and Economical PCR-based Gene Deletion and Modification in Saccharomyces cerevisiae. Yeast. 1998;14:953&#x2013;961. doi: 10.1002/(SICI)1097-0061(199807)14:10&lt;953::AID-YEA293&gt;3.0.CO;2-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0061(199807)14:10&lt;953::AID-YEA293&gt;3.0.CO;2-U</ArticleId><ArticleId IdType="pubmed">9717241</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein A.L., McCusker J.H. Three New Dominant Drug Resistance Cassettes for Gene Disruption in Saccharomyces cerevisiae. Yeast. 1999;15:1541&#x2013;1553. doi: 10.1002/(SICI)1097-0061(199910)15:14&lt;1541::AID-YEA476&gt;3.0.CO;2-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0061(199910)15:14&lt;1541::AID-YEA476&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">10514571</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiestl R.H., Gietz R.D. High Efficiency Transformation of Intact Yeast Cells Using Single Stranded Nucleic Acids as a Carrier. Curr. Genet. 1989;16:339&#x2013;346. doi: 10.1007/BF00340712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00340712</ArticleId><ArticleId IdType="pubmed">2692852</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikorski R.S., Hieter P. A System of Shuttle Vectors and Yeast Host Strains Designed for Efficient Manipulation of DNA in Saccharomyces cerevisiae. Genetics. 1989;122:19&#x2013;27. doi: 10.1093/genetics/122.1.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/122.1.19</ArticleId><ArticleId IdType="pmc">PMC1203683</ArticleId><ArticleId IdType="pubmed">2659436</ArticleId></ArticleIdList></Reference><Reference><Citation>Audhya A., Emr S.D. Regulation of PI4,5P2 Synthesis by Nuclear-Cytoplasmic Shuttling of the Mss4 Lipid Kinase. EMBO J. 2003;22:4223&#x2013;4236. doi: 10.1093/emboj/cdg397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdg397</ArticleId><ArticleId IdType="pmc">PMC175787</ArticleId><ArticleId IdType="pubmed">12912920</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosser D.C., Wrasman K., Woodard T.K., O&#x2019;Donnell A.F., Wendland B. Applications of PHluorin for Quantitative, Kinetic and High-Throughput Analysis of Endocytosis in Budding Yeast. J. Vis. Exp. 2016;116:e54587. doi: 10.3791/54587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/54587</ArticleId><ArticleId IdType="pmc">PMC5092240</ArticleId><ArticleId IdType="pubmed">27805610</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.-Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic Lateral Sclerosis and Structural Defects in Cu,Zn Superoxide Dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Bowling A.C., Patterson D., Usdin T.B., Sapp P., Mezey E., McKenna-Yasek D., O&#x2019;Regan J., Rahmani Z., Ferrante R.J., et al. A Frequent Ala 4 to Val Superoxide Dismutase-1 Mutation Is Associated with a Rapidly Progressive Familial Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 1994;3:981&#x2013;987. doi: 10.1093/hmg/3.6.981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.6.981</ArticleId><ArticleId IdType="pubmed">7951249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogasawara M., Matsubara Y., Narisawa K., Aoki M., Nakamura S., Itoyama Y., Abe K. Mild ALS in Japan Associated with Novel SOD Mutation. Nat. Genet. 1993;5:323&#x2013;324. doi: 10.1038/ng1293-323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1293-323</ArticleId><ArticleId IdType="pubmed">8298637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata J., Hasegawa H., Shimohama S., Kimura J., Tanaka S., Ueda K. Leu106-to-Val (CTC-to-GTC) Mutation of Superoxide Dismutase-1 Gene in Patient with Familial Amyotrophic Lateral Sclerosis in Japan. Lancet. 1994;343:1501. doi: 10.1016/S0140-6736(94)92610-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(94)92610-7</ArticleId><ArticleId IdType="pubmed">7911198</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Keranen M.-L., Bergmark L., Saarinen A., Haltia T., Tarvainen I., et al. Autosomal Recessive Adult-Onset Amyotrophic Lateral Sclerosis Associated with Homozygosity for Asp90Ala CuZn-Superoxide Dismutase Mutation: A Clinical and Genealogical Study of 36 Patients. Brain. 1996;119:1153&#x2013;1172. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M., Abe K., Aoki M., Sahara M., Watanabe M., Shoji M., George-Hyslop P.H.S., Hirai S., Itoyama Y. Variable Clinical Symptoms in Familial Amyotrophic Lateral Sclerosis with a Novel Point Mutation in the Cu/Zn Superoxide Dismutase Gene. Neurology. 1995;45:2038&#x2013;2042. doi: 10.1212/WNL.45.11.2038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.45.11.2038</ArticleId><ArticleId IdType="pubmed">7501156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp P.C., Rosen D.R., Hosler B.A., Esteban J., McKenna-Yasek D., O&#x2019;regan J.P., Horvitz H.R., Brown R.H. Identification of Three Novel Mutations in the Gene for CuZn Superoxide Dismutase in Patients with Familial Amyotrophic Lateral Sclerosis. Neuromuscul. Disord. 1995;5:353&#x2013;357. doi: 10.1016/0960-8966(95)00007-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-8966(95)00007-A</ArticleId><ArticleId IdType="pubmed">7496169</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M., Aoki M., Abe K., Hasegawa T., Sakuma R., Onodera Y., Ichikawa N., Nishizawa M., Itoyama Y. A Novel Two-Base Mutation in the CuZn Superoxide Dismutase Gene Associated with Familial Amyotrophic Lateral Sclerosis in Japan. Neurosci. Lett. 1996;205:79&#x2013;82. doi: 10.1016/0304-3940(96)12378-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12378-8</ArticleId><ArticleId IdType="pubmed">8907321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrzewa M., Damian M.S., M&#xfc;ller U. Superoxide Dismutase 1: Identification of a Novel Mutation in a Case of Familial Amyotrophic Lateral Sclerosis. Hum. Genet. 1996;98:48&#x2013;50. doi: 10.1007/s004390050157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004390050157</ArticleId><ArticleId IdType="pubmed">8682505</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C.T., Swingler R.J., Brock D.J. Identification of a Novel SOD1 Mutation in an Apparently Sporadic Amyotrophic Lateral Sclerosis Patient and the Detection of Ile113Thr in Three Others. Hum. Mol. Genet. 1994;3:649&#x2013;650. doi: 10.1093/hmg/3.4.649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.4.649</ArticleId><ArticleId IdType="pubmed">8069312</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Aoki M., Abe K., Shoji M., Iizuka T., Ikeda Y., Hirai S., Kurokawa K., Kato T., Sasaki H., et al. A Novel Missense Point Mutation (S134N) of the Cu/Zn Superoxide Dismutase Gene in a Patient with Familial Motor Neuron Disease. Hum. Mutat. 1997;9:69&#x2013;71. doi: 10.1002/(SICI)1098-1004(1997)9:1&lt;69::AID-HUMU14&gt;3.0.CO;2-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1004(1997)9:1&lt;69::AID-HUMU14&gt;3.0.CO;2-N</ArticleId><ArticleId IdType="pubmed">8990014</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki M., Abe K., Houi K., Ogasawara M., Matsubara Y., Kobayashi T., Mochio S., Narisawa K., Itoyama Y. Variance of Age at Onset in a Japanese Family with Amyotrophic Lateral Sclerosis Associated with a Novel Cu/Zn Superoxide Dismutase Mutation. Ann. Neurol. 1995;37:676&#x2013;679. doi: 10.1002/ana.410370518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410370518</ArticleId><ArticleId IdType="pubmed">7755363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata J., Shimohama S., Takano S., Harada K., Ueda K., Kimura J. Novel G16S (GGC-AGC) Mutation in the SOD-1 Gene in a Patient with Apparently Sporadic Young-onset Amyotrophic Lateral Sclerosis. Hum. Mutat. 1997;9:356&#x2013;358. doi: 10.1002/(SICI)1098-1004(1997)9:4&lt;356::AID-HUMU9&gt;3.0.CO;2-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1004(1997)9:4&lt;356::AID-HUMU9&gt;3.0.CO;2-3</ArticleId><ArticleId IdType="pubmed">9101297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu J.S., Deng H.-X., Lo T.P., Mitsumoto H., Ahmed M.S., Hung W.-Y., Cai Z.-J., Tainer J.A., Siddique T. Exon 5 Encoded Domain Is Not Required for the Toxic Function of Mutant SOD1 but Essential for the Dismutase Activity: Identification and Characterization of Two New SOD1 Mutations Associated with Familial Amyotrophic Lateral Sclerosis. Neurogenetics. 1997;1:65&#x2013;71. doi: 10.1007/s100480050010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s100480050010</ArticleId><ArticleId IdType="pubmed">10735277</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrell R.W., Marklund S.L., de Belleroche J.S. Familial ALS is Associated with Mutations in All Exons of SOD1: A Novel Mutation in Exon 3 (Gly72Ser) J. Neurol. Sci. 1997;153:46&#x2013;49. doi: 10.1016/S0022-510X(97)00181-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(97)00181-0</ArticleId><ArticleId IdType="pubmed">9455977</ArticleId></ArticleIdList></Reference><Reference><Citation>Penco S., Schenone A., Bordo D., Bolognesi M., Abbruzzese M., Bugiani O., Ajmar F., Garr&#xe8; C. A SOD1 Gene Mutation in a Patient with Slowly Progressing Familial ALS. Neurology. 1999;53:404&#x2013;406. doi: 10.1212/WNL.53.2.404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.2.404</ArticleId><ArticleId IdType="pubmed">10430435</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellera C., Castellotti B., Riggio M.C., Silani V., Morandi L., Testa D., Casali C., Taroni F., Donato S.D., Zeviani M., et al. Superoxide Dismutase Gene Mutations in Italian Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis: Identification of Three Novel Missense Mutations. Neuromuscul. Disord. 2001;11:404&#x2013;410. doi: 10.1016/S0960-8966(00)00215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(00)00215-7</ArticleId><ArticleId IdType="pubmed">11369193</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M.D., Traynor B.J., Miller N., Corr B., Frost E., McQuaid S., Brett F.M., Green A., Hardiman O. &#x201c;True&#x201d; Sporadic ALS Associated with a Novel SOD-1 Mutation. Ann. Neurol. 2002;52:680&#x2013;683. doi: 10.1002/ana.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10369</ArticleId><ArticleId IdType="pubmed">12402272</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoris J., Moulard B., Briolotti V., Hayer M., Durieux A., Clavelou P., Malafosse A., Rouleau G.A., Camu W. Coexistence of Dominant and Recessive Familial Amyotrophic Lateral Sclerosis with the D90A Cu,Zn Superoxide Dismutase Mutation within the Same Country. Eur. J. Neurol. 2000;7:207&#x2013;211. doi: 10.1046/j.1468-1331.2000.00028.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.2000.00028.x</ArticleId><ArticleId IdType="pubmed">10809943</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshafey A., Lanyon W.G., Connor J.M. Identification of a New Missense Point Mutation in Exon 4 of the Cu/Zn Superoxide Dismutase (SOD-1) Gene in a Family with Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 1994;3:363&#x2013;364. doi: 10.1093/hmg/3.2.363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.2.363</ArticleId><ArticleId IdType="pubmed">8004110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezer S., Daana M., Park J.H., Yanovsky-Dagan S., Nordstr&#xf6;m U., Basal A., Edvardson S., Saada A., Otto M., Meiner V., et al. Infantile SOD1 Deficiency Syndrome Caused by a Homozygous SOD1 Variant with Absence of Enzyme Activity. Brain. 2021;145:872&#x2013;878. doi: 10.1093/brain/awab416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab416</ArticleId><ArticleId IdType="pubmed">34788402</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira M.-C., Klur S., Watanabe M., N&#xe9;meth A.H., Ber I.L., Moniz J.-C., Tranchant C., Aubourg P., Tazir M., Sch&#xf6;ls L., et al. Senataxin, the Ortholog of a Yeast RNA Helicase, is Mutant in Ataxia-Ocular Apraxia 2. Nat. Genet. 2004;36:225&#x2013;227. doi: 10.1038/ng1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1303</ArticleId><ArticleId IdType="pubmed">14770181</ArticleId></ArticleIdList></Reference><Reference><Citation>Duquette A., Roddier K., McNabb-Baltar J., Gosselin I., St-Denis A., Dicaire M., Loisel L., Labuda D., Marchand L., Mathieu J., et al. Mutations in Senataxin Responsible for Quebec Cluster of Ataxia with Neuropathy. Ann. Neurol. 2005;57:408&#x2013;414. doi: 10.1002/ana.20408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20408</ArticleId><ArticleId IdType="pubmed">15732101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassuk A.G., Chen Y.Z., Batish S.D., Nagan N., Opal P., Chance P.F., Bennett C.L. In Cis Autosomal Dominant Mutation of Senataxin Associated with Tremor/Ataxia Syndrome. Neurogenetics. 2007;8:45&#x2013;49. doi: 10.1007/s10048-006-0067-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-006-0067-8</ArticleId><ArticleId IdType="pubmed">17096168</ArticleId></ArticleIdList></Reference><Reference><Citation>Asaka T., Yokoji H., Ito J., Yamaguchi K., Matsushima A. Autosomal Recessive Ataxia with Peripheral Neuropathy and Elevated AFP: Novel Mutations in SETX. Neurology. 2006;66:1580&#x2013;1581. doi: 10.1212/01.wnl.0000216135.59699.9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000216135.59699.9b</ArticleId><ArticleId IdType="pubmed">16717225</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel B.L., Perlman S. Novel Mutations in the Senataxin DNA/RNA Helicase Domain in Ataxia with Oculomotor Apraxia 2. Neurology. 2006;67:2083&#x2013;2084. doi: 10.1212/01.wnl.0000247661.19601.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000247661.19601.28</ArticleId><ArticleId IdType="pubmed">17159128</ArticleId></ArticleIdList></Reference><Reference><Citation>Anheim M., Fleury M.-C., Franques J., Moreira M.-C., Delaunoy J.-P., Stoppa-Lyonnet D., Koenig M., Tranchant C. Clinical and Molecular Findings of Ataxia with Oculomotor Apraxia Type 2 in 4 Families. Arch. Neurol. 2008;65:958&#x2013;962. doi: 10.1001/archneur.65.7.958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.7.958</ArticleId><ArticleId IdType="pubmed">18625865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-J., Anagnostou G., Chai A., Withers J., Morris A., Adhikaree J., Pennetta G., de Belleroche J.S. Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis. J. Biol. Chem. 2010;285:40266&#x2013;40281. doi: 10.1074/jbc.M110.161398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.161398</ArticleId><ArticleId IdType="pmc">PMC3001007</ArticleId><ArticleId IdType="pubmed">20940299</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Zhang Y., Dowling J.J., Jin N., Adamska M., Shiga K., Szigeti K., Shy M.E., Li J., Zhang X., et al. Mutation of FIG4 Causes Neurodegeneration in the Pale Tremor Mouse and Patients with CMT4J. Nature. 2007;448:68&#x2013;72. doi: 10.1038/nature05876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05876</ArticleId><ArticleId IdType="pmc">PMC2271033</ArticleId><ArticleId IdType="pubmed">17572665</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S., et al. Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS. Am. J. Hum. Genet. 2009;84:85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona-Rivera J.R., Romo-Huerta C.O., L&#xf3;pez-Marure E., Ramos F.J., Estrada-Padilla S.A., Zepeda-Romero L.C. New Ocular Findings in Two Sisters with Yunis&#x2013;Var&#xf3;n Syndrome and Literature Review. Eur. J. Med. Genet. 2011;54:76&#x2013;81. doi: 10.1016/j.ejmg.2010.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2010.09.013</ArticleId><ArticleId IdType="pubmed">20932945</ArticleId></ArticleIdList></Reference><Reference><Citation>Campeau P.M., Lenk G.M., Lu J.T., Bae Y., Burrage L., Turnpenny P., Corona-Rivera J.R., Morandi L., Mora M., Reutter H., et al. Yunis-Var&#xf3;n Syndrome is Caused by Mutations in FIG4, Encoding a Phosphoinositide Phosphatase. Am. J. Hum. Genet. 2013;92:781&#x2013;791. doi: 10.1016/j.ajhg.2013.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.03.020</ArticleId><ArticleId IdType="pmc">PMC3644641</ArticleId><ArticleId IdType="pubmed">23623387</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson G., Lenk G.M., Reddel S.W., Grant A.E., Towne C.F., Ferguson C.J., Simpson E., Scheuerle A., Yasick M., Hoffman S., et al. Distinctive Genetic and Clinical Features of CMT4J: A Severe Neuropathy Caused by Mutations in the PI(3,5)P&#x2082; Phosphatase FIG4. Brain J. Neurol. 2011;134:1959&#x2013;1971. doi: 10.1093/brain/awr148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr148</ArticleId><ArticleId IdType="pmc">PMC3122378</ArticleId><ArticleId IdType="pubmed">21705420</ArticleId></ArticleIdList></Reference><Reference><Citation>Baulac S., Lenk G.M., Dufresnois B., Bencheikh B.O.A., Couarch P., Renard J., Larson P.A., Ferguson C.J., No&#xe9; E., Poirier K., et al. Role of the Phosphoinositide Phosphatase FIG4 Gene in Familial Epilepsy with Polymicrogyria. Neurology. 2014;82:1068&#x2013;1075. doi: 10.1212/WNL.0000000000000241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000241</ArticleId><ArticleId IdType="pmc">PMC3962989</ArticleId><ArticleId IdType="pubmed">24598713</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulst S.M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., et al. Moderate Expansion of a Normally Biallelic Trinucleotide Repeat in Spinocerebellar Ataxia Type 2. Nat. Genet. 1996;14:269&#x2013;276. doi: 10.1038/ng1196-269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1196-269</ArticleId><ArticleId IdType="pubmed">8896555</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G.D.J., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion Body Myopathy Associated with Paget Disease of Bone and Frontotemporal Dementia is Caused by Mutant Valosin-Containing Protein. Nat. Genet. 2004;36:377&#x2013;381. doi: 10.1038/ng1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1332</ArticleId><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Haubenberger D., Bittner R.E., Rauch-Shorny S., Zimprich F., Mannhalter C., Wagner L., Mineva I., Vass K., Auff E., Zimprich A. Inclusion Body Myopathy and Paget Disease Is Linked to a Novel Mutation in the VCP Gene. Neurology. 2005;65:1304&#x2013;1305. doi: 10.1212/01.wnl.0000180407.15369.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000180407.15369.92</ArticleId><ArticleId IdType="pubmed">16247064</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Deerlin V.M.V., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M.A., Feely S.M., Speziani F., Strickland A.V., Danzi M., Bacon C., Lee Y., Chou T.-F., Blanton S.H., Weihl C.C., et al. A Novel Mutation in VCP Causes Charcot&#x2013;Marie&#x2013;Tooth Type 2 Disease. Brain. 2014;137:2897&#x2013;2902. doi: 10.1093/brain/awu224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu224</ArticleId><ArticleId IdType="pmc">PMC4208462</ArticleId><ArticleId IdType="pubmed">25125609</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerath N.U., Crockett C.D., Moore S.A., Shy M.E., Weihl C.C., Chou T.-F., Grider T., Gonzalez M.A., Zuchner S., Swenson A. Rare Manifestation of a c.290 C&gt;T, p.Gly97Glu VCP Mutation. Case Rep. Genet. 2015;2015:239167. doi: 10.1155/2015/239167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/239167</ArticleId><ArticleId IdType="pmc">PMC4386706</ArticleId><ArticleId IdType="pubmed">25878907</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahao A., Neto O.A., Kok F., Zanoteli E., Santos B., de Rezende Pinto W.B.V., Barsottini O.G.P., Oliveira A.S.B., Pedroso J.L. One Family, One Gene and Three Phenotypes: A Novel VCP (Valosin-Containing Protein) Mutation Associated with Myopathy with Rimmed Vacuoles, Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. J. Neurol. Sci. 2016;368:352&#x2013;358. doi: 10.1016/j.jns.2016.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.07.048</ArticleId><ArticleId IdType="pubmed">27538664</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwich N.F., Phan J.M., Kim B., Suh E., Papatriantafyllou J.D., Changolkar L., Nguyen A.T., O&#x2019;Rourke C.M., He Z., Porta S., et al. Autosomal Dominant VCP Hypomorph Mutation Impairs Disaggregation of PHF-Tau. Science. 2020;370:eaay8826. doi: 10.1126/science.aay8826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay8826</ArticleId><ArticleId IdType="pmc">PMC7818661</ArticleId><ArticleId IdType="pubmed">33004675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.H., Pottier C., Hondius D., Meeter L.H.H., van Rooij J.G.J., Melhem S., Bank T.N.B., van Minkelen R., van Duijn C.M., Rozemuller A.J.M., et al. Three VCP Mutations in Patients with Frontotemporal Dementia. J. Alzheimer&#x2019;s Dis. 2018;65:1139&#x2013;1146. doi: 10.3233/JAD-180301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180301</ArticleId><ArticleId IdType="pubmed">30103325</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., Bohlega S. A Mutation in Sigma-1 Receptor Causes Juvenile Amyotrophic Lateral Sclerosis. Ann. Neurol. 2011;70:913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., et al. Mutations in the Endosomal ESCRTIII-Complex Subunit CHMP2B in Frontotemporal Dementia. Nat. Genet. 2005;37:806&#x2013;808. doi: 10.1038/ng1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1609</ArticleId><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson N., Ince P.G., Smith M.O., Highley R., Skibinski G., Andersen P.M., Morrison K.E., Pall H.S., Hardiman O., Collinge J., et al. ALS Phenotypes with Mutations in CHMP2B (Charged Multivesicular Body Protein 2B) Neurology. 2006;67:1074&#x2013;1077. doi: 10.1212/01.wnl.0000231510.89311.8b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000231510.89311.8b</ArticleId><ArticleId IdType="pubmed">16807408</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J., Urwin H., Engelborghs S., Bruyland M., Vandenberghe R., Dermaut B., Pooter T.D., Peeters K., Santens P., Deyn P.P.D., et al. CHMP2B C-Truncating Mutations in Frontotemporal Lobar Degeneration Are Associated with an Aberrant Endosomal Phenotype in Vitro. Hum. Mol. Genet. 2007;17:313&#x2013;322. doi: 10.1093/hmg/ddm309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm309</ArticleId><ArticleId IdType="pubmed">17956895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.-D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in Prion-like Domains in HnRNPA2B1 and HnRNPA1 Cause Multisystem Proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Ticozzi N., Fallini C., Gkazi A.S., Topp S., Kenna K.P., Scotter E.L., Kost J., Keagle P., Miller J.W., et al. Exome-Wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS. Neuron. 2014;84:324&#x2013;331. doi: 10.1016/j.neuron.2014.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Strassel C., Magiera M.M., Dupuis A., Batzenschlager M., Hovasse A., Pleines I., Gu&#xe9;guen P., Eckly A., Moog S., Mallo L., et al. An Essential Role for A4A-Tubulin in Platelet Biogenesis. Life Sci. Alliance. 2019;2:e201900309. doi: 10.26508/lsa.201900309.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900309</ArticleId><ArticleId IdType="pmc">PMC6374996</ArticleId><ArticleId IdType="pubmed">30760556</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid E., Kloos M., Ashley-Koch A., Hughes L., Bevan S., Svenson I.K., Graham F.L., Gaskell P.C., Dearlove A., Pericak-Vance M.A., et al. A Kinesin Heavy Chain (KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10) Am. J. Hum. Genet. 2002;71:1189&#x2013;1194. doi: 10.1086/344210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/344210</ArticleId><ArticleId IdType="pmc">PMC385095</ArticleId><ArticleId IdType="pubmed">12355402</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichera M., Giudice M.L., Falco M., Sturnio M., Amata S., Calabrese O., Bigoni S., Calzolari E., Neri M. Evidence of Kinesin Heavy Chain (KIF5A) Involvement in Pure Hereditary Spastic Paraplegia. Neurology. 2004;63:1108&#x2013;1110. doi: 10.1212/01.WNL.0000138731.60693.D2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000138731.60693.D2</ArticleId><ArticleId IdType="pubmed">15452312</ArticleId></ArticleIdList></Reference><Reference><Citation>Goizet C., Boukhris A., Mundwiller E., Tallaksen C., Forlani S., Toutain A., Carriere N., Paquis V., Depienne C., Durr A., et al. Complicated Forms of Autosomal Dominant Hereditary Spastic Paraplegia Are Frequent in SPG10. Hum. Mutat. 2009;30:E376&#x2013;E385. doi: 10.1002/humu.20920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20920</ArticleId><ArticleId IdType="pubmed">18853458</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimella C., Baschirotto C., Arnoldi A., Tonelli A., Tenderini E., Airoldi G., Martinuzzi A., Trabacca A., Losito L., Scarlato M., et al. Mutations in the Motor and Stalk Domains of KIF5A in Spastic Paraplegia Type 10 and in Axonal Charcot&#x2013;Marie&#x2013;Tooth Type 2. Clin. Genet. 2012;82:157&#x2013;164. doi: 10.1111/j.1399-0004.2011.01717.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2011.01717.x</ArticleId><ArticleId IdType="pubmed">21623771</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-T., Laur&#xe1; M., Hersheson J., Horga A., Jaunmuktane Z., Brandner S., Pittman A., Hughes D., Polke J.M., Sweeney M.G., et al. Extended Phenotypic Spectrum of KIF5A Mutations. Neurology. 2014;83:612&#x2013;619. doi: 10.1212/WNL.0000000000000691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000691</ArticleId><ArticleId IdType="pmc">PMC4141994</ArticleId><ArticleId IdType="pubmed">25008398</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawkins J.L., Hulme D.J., Brahmbhatt S.B., Auer-Grumbach M., Nicholson G.A. Mutations in SPTLC1, Encoding Serine Palmitoyltransferase, Long Chain Base Subunit-1, Cause Hereditary Sensory Neuropathy Type I. Nat. Genet. 2001;27:309&#x2013;312. doi: 10.1038/85879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/85879</ArticleId><ArticleId IdType="pubmed">11242114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejaoui K., Wu C., Scheffler M.D., Haan G., Ashby P., Wu L., de Jong P., Brown R.H. SPTLC1 is Mutated in Hereditary Sensory Neuropathy, Type 1. Nat. Genet. 2001;27:261&#x2013;262. doi: 10.1038/85817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/85817</ArticleId><ArticleId IdType="pubmed">11242106</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotthier A., Baets J., Vriendt E.D., Jacobs A., Auer-Grumbach M., L&#xe9;vy N., Bonello-Palot N., Kilic S.S., Weis J., Nascimento A., et al. Genes for Hereditary Sensory and Autonomic Neuropathies: A Genotype&#x2013;Phenotype Correlation. Brain. 2009;132:2699&#x2013;2711. doi: 10.1093/brain/awp198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp198</ArticleId><ArticleId IdType="pmc">PMC2759337</ArticleId><ArticleId IdType="pubmed">19651702</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M., Bode H., Pieber T.R., Schabh&#xfc;ttl M., Fischer D., Seidl R., Graf E., Wieland T., Schuh R., Vacariu G., et al. Mutations at Ser331 in the HSN Type I Gene SPTLC1 are Associated with a Distinct Syndromic Phenotype. Eur. J. Med. Genet. 2013;56:266&#x2013;269. doi: 10.1016/j.ejmg.2013.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2013.02.002</ArticleId><ArticleId IdType="pmc">PMC3682180</ArticleId><ArticleId IdType="pubmed">23454272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P., Donkervoort S., Lone M.A., Nalls M., Gable K., Gupta S.D., Foley A.R., Hu Y., Saute J.A.M., Moreira A.L., et al. Childhood Amyotrophic Lateral Sclerosis Caused by Excess Sphingolipid Synthesis. Nat. Med. 2021;27:1197&#x2013;1204. doi: 10.1038/s41591-021-01346-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01346-1</ArticleId><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A Mitochondrial Origin for Frontotemporal Dementia and Amyotrophic Lateral Sclerosis through CHCHD10 Involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Penttil&#xe4; S., Jokela M., Bouquin H., Saukkonen A.M., Toivanen J., Udd B. Late Onset Spinal Motor Neuronopathy is Caused by Mutation in CHCHD10. Ann. Neurol. 2015;77:163&#x2013;172. doi: 10.1002/ana.24319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24319</ArticleId><ArticleId IdType="pubmed">25428574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S., Fecto F., Ajroud K., Lalani I., Calvo S.E., Mootha V.K., Deng H.-X., Siddique N., Tahmoush A.J., Heiman-Patterson T.D., et al. Mutation in the Novel Nuclear-Encoded Mitochondrial Protein CHCHD10 in a Family with Autosomal Dominant Mitochondrial Myopathy. Neurogenetics. 2015;16:1&#x2013;9. doi: 10.1007/s10048-014-0421-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0421-1</ArticleId><ArticleId IdType="pmc">PMC4796476</ArticleId><ArticleId IdType="pubmed">25193783</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Topp S., Yang S., Smith B., Fifita J.A., Warraich S.T., Zhang K.Y., Farrawell N., Vance C., Hu X., et al. CCNF Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Nat. Commun. 2016;7:11253. doi: 10.1038/ncomms11253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord S.J., Velle K.B., Mullins R.D., Fritz-Laylin L.K. SuperPlots: Communicating Reproducibility and Variability in Cell Biology. J. Cell Biol. 2020;219:e202001064. doi: 10.1083/jcb.202001064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202001064</ArticleId><ArticleId IdType="pmc">PMC7265319</ArticleId><ArticleId IdType="pubmed">32346721</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkas C., Wardrope C., Hannah M., Skehel P. The ALS8-Associated Mutant VAPBP56S Is Resistant to Proteolysis in Neurons. J. Neurochem. 2011;117:286&#x2013;294. doi: 10.1111/j.1471-4159.2011.07201.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07201.x</ArticleId><ArticleId IdType="pubmed">21275991</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes G., Hansen W.J., Holcomb C.L., Rine J. Asparagine-Linked Glycosylation in Saccharomyces cerevisiae: Genetic Analysis of an Early Step. Mol. Cell Biol. 1984;4:2381&#x2013;2388. doi: 10.1128/mcb.4.11.2381-2388.1984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.4.11.2381-2388.1984</ArticleId><ArticleId IdType="pmc">PMC369068</ArticleId><ArticleId IdType="pubmed">6096695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B., Baryshnikova A., Brown G.W. Unification of Protein Abundance Datasets Yields a Quantitative Saccharomyces cerevisiae Proteome. Cell Syst. 2018;6:192&#x2013;205.e3. doi: 10.1016/j.cels.2017.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2017.12.004</ArticleId><ArticleId IdType="pubmed">29361465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., O&#x2019;Shea E.K., Weissman J.S. Global Analysis of Protein Expression in Yeast. Nature. 2003;425:737&#x2013;741. doi: 10.1038/nature02046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02046</ArticleId><ArticleId IdType="pubmed">14562106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulak N.A., Pichler G., Paron I., Nagaraj N., Mann M. Minimal, Encapsulated Proteomic-Sample Processing Applied to Copy-Number Estimation in Eukaryotic Cells. Nat. Meth. 2014;11:319&#x2013;324. doi: 10.1038/nmeth.2834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2834</ArticleId><ArticleId IdType="pubmed">24487582</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraj N., Kulak N.A., Cox J., Neuhauser N., Mayr K., Hoerning O., Vorm O., Mann M. System-Wide Perturbation Analysis with Nearly Complete Coverage of the Yeast Proteome by Single-Shot Ultra HPLC Runs on a Bench Top Orbitrap. Mol. Cell. Proteom. 2012;11:M111.013722. doi: 10.1074/mcp.M111.013722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M111.013722</ArticleId><ArticleId IdType="pmc">PMC3316726</ArticleId><ArticleId IdType="pubmed">22021278</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M., Taouatas N., Cappadona S., van Breukelen B., Mohammed S., Scholten A., Heck A.J.R. Protease Bias in Absolute Protein Quantitation. Nat. Meth. 2012;9:524&#x2013;525. doi: 10.1038/nmeth.2031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2031</ArticleId><ArticleId IdType="pubmed">22669647</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb K.J., Xu T., Park S.K., Yates J.R. Modified MuDPIT Separation Identified 4488 Proteins in a System-Wide Analysis of Quiescence in Yeast. J. Proteome Res. 2013;12:2177&#x2013;2184. doi: 10.1021/pr400027m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400027m</ArticleId><ArticleId IdType="pmc">PMC3815592</ArticleId><ArticleId IdType="pubmed">23540446</ArticleId></ArticleIdList></Reference><Reference><Citation>Yofe I., Weill U., Meurer M., Chuartzman S., Zalckvar E., Goldman O., Ben-Dor S., Sch&#xfc;tze C., Wiedemann N., Knop M., et al. One Library to Make Them All: Streamlining the Creation of Yeast Libraries via a SWAp-Tag Strategy. Nat. Meth. 2016;13:371&#x2013;378. doi: 10.1038/nmeth.3795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3795</ArticleId><ArticleId IdType="pmc">PMC4869835</ArticleId><ArticleId IdType="pubmed">26928762</ArticleId></ArticleIdList></Reference><Reference><Citation>Treusch S., Hamamichi S., Goodman J.L., Matlack K.E.S., Chung C.Y., Baru V., Shulman J.M., Parrado A., Bevis B.J., Valastyan J.S., et al. Functional Links between A&#x3b2; Toxicity, Endocytic Trafficking, and Alzheimer&#x2019;s Disease Risk Factors in Yeast. Science. 2011;334:1241&#x2013;1245. doi: 10.1126/science.1213210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1213210</ArticleId><ArticleId IdType="pmc">PMC3281757</ArticleId><ArticleId IdType="pubmed">22033521</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., et al. Alpha-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson&#x2019;s Models. Science. 2006;313:324&#x2013;328. doi: 10.1126/science.1129462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1129462</ArticleId><ArticleId IdType="pmc">PMC1983366</ArticleId><ArticleId IdType="pubmed">16794039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevis B.J., Hammond A.T., Reinke C.A., Glick B.S. De Novo Formation of Transitional ER Sites and Golgi Structures in Pichia Pastoris. Nat. Cell Biol. 2002;4:750&#x2013;756. doi: 10.1038/ncb852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb852</ArticleId><ArticleId IdType="pubmed">12360285</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikawa J., Murakami A., Esumi E., Hosaka K. Cloning and Sequence of the SCS2 Gene, Which Can Suppress the Defect of INO1 Expression in an Inositol Auxotrophic Mutant of Saccharomyces cerevisiae. J. Biochem. 1995;118:39&#x2013;45. doi: 10.1093/oxfordjournals.jbchem.a124889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a124889</ArticleId><ArticleId IdType="pubmed">8537323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kachroo A.H., Laurent J.M., Yellman C.M., Meyer A.G., Wilke C.O., Marcotte E.M. Systematic Humanization of Yeast Genes Reveals Conserved Functions and Genetic Modularity. Science. 2015;348:921&#x2013;925. doi: 10.1126/science.aaa0769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa0769</ArticleId><ArticleId IdType="pmc">PMC4718922</ArticleId><ArticleId IdType="pubmed">25999509</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor E.L., Galtrey C.M., Perkinton M.S., Lau K.-F., Vos K.J.D., Mitchell J.C., Ackerley S., Hortob&#xe1;gyi T., V&#xe1;mos E., Leigh P.N., et al. Amyotrophic Lateral Sclerosis Mutant Vesicle-Associated Membrane Protein-Associated Protein-B Transgenic Mice Develop TAR-DNA-Binding Protein-43 Pathology. Neuroscience. 2010;167:774&#x2013;785. doi: 10.1016/j.neuroscience.2010.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.035</ArticleId><ArticleId IdType="pubmed">20188146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Oussini H.E., Bercier V., Gros-Louis F., Valdmanis P.N., McDearmid J., Mejier I.A., Dion P.A., Dupre N., Hollinger D., et al. Investigating the Contribution of VAPB/ALS8 Loss of Function in Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2013;22:2350&#x2013;2360. doi: 10.1093/hmg/ddt080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt080</ArticleId><ArticleId IdType="pubmed">23446633</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Colavita A., Ngsee J.K. Mitigating Motor Neuronal Loss in C. Elegans Model of ALS8. Sci. Rep. 2017;7:11582. doi: 10.1038/s41598-017-11798-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11798-6</ArticleId><ArticleId IdType="pmc">PMC5599522</ArticleId><ArticleId IdType="pubmed">28912432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai A., Withers J., Koh Y.H., Parry K., Bao H., Zhang B., Budnik V., Pennetta G. HVAPB, the Causative Gene of a Heterogeneous Group of Motor Neuron Diseases in Humans, is Functionally Interchangeable with Its Drosophila Homologue DVAP-33A at the Neuromuscular Junction. Hum. Mol. Genet. 2008;17:266&#x2013;280. doi: 10.1093/hmg/ddm303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm303</ArticleId><ArticleId IdType="pmc">PMC3516386</ArticleId><ArticleId IdType="pubmed">17947296</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>